Top Contract Manufacturing Organizations-2023
Pharma Tech Outlook
BioSpectra Inc.: Where Manufacturing Meets Mobility: Innovating & Securing The Pharmaceutical Supply Chain
line

Top 10 Contract Manufacturing Organizations - 2023

line

Over the past decade, contract manufacturing has rapidly gained popularity, particularly in the pharmaceutical and biotechnology industries. As a result, Contract Manufacturing Organizations (CMOs) have become an integral part of the supply chain. The global pharmaceutical CMO market was valued at USD 134.12 billion in 2021 and is expected to reach USD 204.14 billion by 2027, with a compound annual growth rate (CAGR) of 6.64 percent from 2022 to 2027.

Many pharmaceutical companies are now recognizing the potential profitability of working with a CMO for both clinical and commercial-stage manufacturing. This is mainly due to the increasing demand for generic medications and biologics, the capital-intensive nature of the industry, and the complex manufacturing requirements.

One of the significant factors driving the growth of CMOs in the pharmaceutical industry is the need for state-of-the-art processes and production technologies. These technologies have proven to be significantly effective in meeting regulatory requirements, which is becoming increasingly important as the industry becomes more heavily regulated. Therefore, partnering with a CMO can help pharmaceutical companies stay competitive and compliant while focusing on their core competencies.

In this edition of Pharma Tech Outlook, we present some of the most promising Contract Manufacturing Organizations along with thought leadership articles from Yvonne Ware, Associate Director, Manufacturing Operations at BioNTech SE, Max Brescia, Senior Global Director, Contract Manufacturing at AbbVie and Franck A. Vendeix, PhD, Associate Director, Analytical Services, AMRI (now Curia).

The magazine highlights BioSpectra, a leader in producing pharmaceutical-grade ingredients, including biological buffers, actives, excipients, GMP process chemicals, and new chemical entities (NCEs) at ICH Q7 levels. The publication also features other companies including Dipharma, a global Contract Development and Manufacturing Organisation (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients.

Leafing through these pages will give you comprehensive insights into the innovative trends and latest developments in the CMO landscape. 

    Top Contract Manufacturing Organizations

    BioSpectra, Inc (BSI) is a leader in manufacturing pharmaceutical-grade ingredients, including biological buffers, actives, excipients, GMP process chemicals, and new chemical entities (NCEs) at ICH Q7 levels. Focused on small molecule synthesis and true, phase change multi-step purification, this high-value entity secures the supply chain and solutions for a range of key ingredient issues that its clients face. ... read full profile
    AGC Biologics is a leading CDMO for protein-based biologics and cell & gene therapies, from development to clinical trials, to full-scale commercialization using its global resources. Overall, it is on a mission to enhance patient health by bringing new and quality biopharmaceuticals ... read full profile
    Altasciences is revolutionizing the pharmaceutical industry with its integrated CRO and CDMO services, delivering substantial cost and time savings. The organization’s proactive, adaptable approach, broad service offerings, and dedication to client needs exemplify their commitment to excellence and efficient drug development. ... read full profile
    PL Development/Avéma Pharma Solutions is a leading CDMO with the expertise and production capabilities to manufacture gummies in addition to solid and liquid dose forms. With more than three decades of experience in the pharmaceutical industry, the company is positioned to be a key player in the manufacturing, packaging, and distribution of gummies. ... read full profile
    Dipharma is a global CDMO and a leading manufacturer of active pharmaceutical ingredients (API) and intermediates. It serves top-ranking pharmaceutical companies in Europe, the U.S.A., and Japan. ... read full profile
    A division of Miltenyi Biotec, Miltenyi Bioindustry is a full-scale contract development and manufacturing organization (CDMO), providing customers with services for the development and manufacturing of lentiviral vectors (LVVs) and CGT products. ... read full profile
    Polysciences provides life sciences, bioprocessing, microparticles, medical device, specialty chemical, and electronic chemical industries with a wide range of products and tailored solutions along with custom synthesis and contract manufacturing services. The company’s quality management system is ISO 18345-certified, which is a testament to its focus on safety and quality. ... read full profile
    ABL
    With a history of more than 60 years as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and immunological testing capabilities.
    Andelyn Biosciences
    Andelyn Biosciences is a gene therapy CDMO with deep expertise and experience in the development and production of viral vectors
    Center for Breakthrough Medicines
    Center for Breakthrough Medicines is an innovative cell and gene therapy focused contract development and manufacturing organization. CBM’s integrated and comprehensive service offering provides a onesource solution to accelerate speed to market for advanced therapies.